Shinji Fukushima

Dr. Shinji Fukushima

Travellers' Medical Center, Tokyo Medical University, Tokyo, Japan
orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 June 2017 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
ASAkihiro Sato
Akihiro Sato
INItaru Nakamura
Itaru Nakamura
HFHiroaki Fujita
Hiroaki Fujita
ATAyaka Tsukimori
Ayaka Tsukimori
TKTakehito Kobayashi
Takehito Kobayashi
TMTetsuya Matsumoto
Tetsuya Matsumoto
The purpose of this study was to identify the clinical characteristics and outcomes of peripheral vascular catheter-related bloodstream infections (PVC-BSIs) and determine the risk of severe complications or death. We performed a retrospective observational study from June 2010 to April 2015 at two regional university-affiliated hospitals in Tokyo. We studied the clinical manifestations, underlying diseases, laboratory results, treatment methods, recurrence rates, and complications in 62 hospitalized patients diagnosed with PVC-BSIs by positive blood cultures. The median time from admission to bacteremia was 17 days (range, 3–142 days) and that from catheter insertion to bacteremia diagnosis was 6 days (range, 2–15 days). Catheter insertion sites were in the arm in 48 (77.4%) patients, in the foot in 3 (4.8%) patients, and in an unrecorded location in 11 (17.7%) patients. Additionally, the causative pathogens were Gram-positive microorganisms in 58.0% of cases, Gram-negative microorganisms in 35.8% of cases, Candida spp. in 6.2% of cases, and polymicrobials in 25.8% of cases. Eight (12.9%) patients died within 30 days of their blood culture becoming positive. Patients who died of PVC-BSIs had a higher proportion of Staphylococcus aureus infection than patients who survived (odds ratio, 8.33; p = 0.004). PVC-BSIs are a significant cause of health care-associated infection. We observed cases of severe PVC-BSI requiring intensive and long-term care along with lengthy durations of antibiotic treatment due to hematogenous complications, and some patients died. For patients with PVC-BSIs, S. aureus bacteremia remains a major problem that may influence the prognosis.

1 January 2013 in Journal of Infection and Chemotherapy
Verified
Journal Article
Closed access
HSHiroyuki Shimizu
Hiroyuki Shimizu
YMYasutaka Mizuno
Yasutaka Mizuno
INItaru Nakamura
Itaru Nakamura
SFShinji Fukushima
Shinji Fukushima
TMTetsuya Matsumoto
Tetsuya Matsumoto
KEKenji Endo
Kenji Endo

19 September 2016 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
TKTakehito Kobayashi
Takehito Kobayashi
INItaru Nakamura
Itaru Nakamura
HFHiroaki Fujita
Hiroaki Fujita
ATAyaka Tsukimori
Ayaka Tsukimori
ASAkihiro Sato
Akihiro Sato
TMTetsuya Matsumoto
Tetsuya Matsumoto
Cupriavidus gilardii is an aerobic, Gram-negative, glucose-nonfermenting rod that was first identified in 1999. Because of the difficulty in accurate species identification of C. gilardii, there are few case reports of infection caused by this organism. In previous reports, C. gilardii has been characterized as an organism with low pathogenicity that causes opportunistic infections. We encountered a case of pacemaker-associated bloodstream infection caused by C. gilardii in a 90-year old woman without obvious immunodeficiency. We identified the isolates as C. gilardii by sequencing of the 16S rRNA gene. The patient was treated with removal of the lead and administration of antimicrobial agents. Because of the acquisition of antibiotic resistance during antibiotic treatment, the antimicrobial agent was changed during the course of treatment. To our knowledge, this is the first report of an infection caused by this organism in a patient without obvious immunodeficiency. Although the true pathogenicity of C. gilardii is unclear, the possibility that it exerts pathogenicity not only in persons with immunodeficiency but also in immunocompetent persons is suggested.

28 June 2018 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
TKTakuya Kusakabe
Takuya Kusakabe
KEKenji Endo
Kenji Endo
INItaru Nakamura
Itaru Nakamura
HSHidekazu Suzuki
Hidekazu Suzuki
HNHirosuke Nishimura
Hirosuke Nishimura
KYKengo Yamamoto
Kengo Yamamoto
Although intravesical bacille Calmette-Guérin (BCG) therapy is accepted as an effective treatment for bladder cancer, serious complications may occur in rare cases. To date, only 4 cases have been reported in which the patient developed a combination of mycotic aortic aneurysm and BCG spondylitis. Accurate diagnosis of BCG spondylitis is important because it is an iatrogenic disease, and its treatment is different from usual tuberculous spondylitis. However, distinguishing BCG spondylitis from usual tuberculous spondylitis is very difficult and takes a long time. In this study, we were able to suspect BCG spondylitis at an early stage from the result of the interferon-gamma release assay (IGRA). We encountered a case of BCG spondylitis with adjacent mycotic aortic aneurysm after intravesical BCG therapy in a 76-year-old man. We performed a 2-stage operation to obtain spine stabilization and replace the aneurysm with a synthetic graft. We started multidrug therapy with antituberculosis medication, excluding pyrazinamide, because the patient’s history of BCG therapy, negative IGRA, and positive of tuberculosis-polymerase chain reaction (Tb-PCR) suggested that the pathogenic bacteria of the spondylitis was BCG. Eventually the bacterial strain was identified as BCG by PCR-based genomic deletion analysis. BCG infection should be considered in patients who have been treated with BCG therapy, even if the treatment was performed several months to several years previously. In the case of a patient with a history of BCG therapy, a positive Tb-PCR result and negative IGRA result probably suggest BCG infections, if the possibility of false-negative IGRA result can be excluded.

29 July 2014 in European Journal of Clinical Microbiology & Infectious Diseases
Verified
Journal Article
Closed access
PDF file
INI. Nakamura
I. Nakamura
TYTetsuo Yamaguchi
Tetsuo Yamaguchi
ATA. Tsukimori
A. Tsukimori
ASA. Sato
A. Sato
SFShinji Fukushima
Shinji Fukushima
TMT. Matsumoto
T. Matsumoto

1 February 2019 in American Journal of Infection Control
Verified
Journal Article
Closed access
INItaru Nakamura
Itaru Nakamura
HFHiroaki Fujita
Hiroaki Fujita
ATAyaka Tsukimori
Ayaka Tsukimori
TKTakehito Kobayashi
Takehito Kobayashi
ASAkihiro Sato
Akihiro Sato
YAYukie Abe
Yukie Abe